Company profile
MEDiSTRAVA, an Inizio Company
- Industry
- Pharmaceutical Manufacturing
- Employees
- 98
- Headquarters
- London, England
- LinkedIn followers
- 3,697
- Office locations
- 2
MEDiSTRAVA, an Inizio Company company summary
MEDiSTRAVA, an Inizio Company is a company in the Pharmaceutical Manufacturing industry, headquartered in London, England. On LinkedIn the company has around 98 employees and 3,697 followers. The company lists 2 office locations. Its listed specialties include Medical Affairs, Health Economics, Publications, Medical Education, Market Access.
What technology does MEDiSTRAVA, an Inizio Company use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About MEDiSTRAVA, an Inizio Company
Specialists in the future of medical communications. We are MEDiSTRAVA, integrated partners from start-up through commercialization and beyond, supporting biotech and biopharma teams. We provide best-in-class specialized services with the ability to collaborate across a broad network of teams within Inizio Medical. Proudly part of Inizio – the market-leading commercialization partner for health and life sciences. From early-stage development to loss of exclusivity, we simplify complexity, unlock value, and make collaboration seamless at every pivotal moment – accelerating the path from innovation to access.
Specialties
Where is MEDiSTRAVA, an Inizio Company located?
MEDiSTRAVA, an Inizio Company lists 2 office locations.
Compare companies similar to MEDiSTRAVA, an Inizio Company
More companies in Pharmaceutical Manufacturing.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
MEDiSTRAVA, an Inizio Company medistrava.com | Pharmaceutical Manufacturing | 98 | - | London, England |
 Anacor Pharmaceuticals pfizer.com | Pharmaceutical Manufacturing | 108,102 | - | New York, New York |
 Sanofi sanofi.com | Pharmaceutical Manufacturing | 93,352 | - | Paris, France, FR |
 GSK gsk.com | Pharmaceutical Manufacturing | 92,179 | - | London, England |
 Novartis España novartis.com | Pharmaceutical Manufacturing | 85,373 | - | Basel, Baselstadt |
 AstraZeneca astrazeneca.com | Pharmaceutical Manufacturing | 80,667 | - | Cambridge, Cambridgeshire, GB |
 Eli Lilly and Company lilly.com | Pharmaceutical Manufacturing | 57,202 | - | Indianapolis, Indiana |
 Merck merck.us | Pharmaceutical Manufacturing | 44,794 | - | Rahway, New Jersey |
 SUN PHARMA sunpharma.com | Pharmaceutical Manufacturing | 47,764 | 1983 | Mumbai, Maharastra |
 Boehringer Ingelheim boehringer-ingelheim.com | Pharmaceutical Manufacturing | 47,150 | - | Ingelheim am Rhein, Rhineland-Palatinate |
 Cipla cipla.com | Pharmaceutical Manufacturing | 51,911 | - | Mumbai, Maharashtra |
Frequently asked questions about MEDiSTRAVA, an Inizio Company
What does MEDiSTRAVA, an Inizio Company do?
Specialists in the future of medical communications. We are MEDiSTRAVA, integrated partners from start-up through commercialization and beyond, supporting biotech and biopharma teams. We provide best-in-class specialized services with the ability to collaborate across a broad network of teams within Inizio Medical. Proudly part of Inizio – the market-leading commercialization partner for health and life sciences. From early-stage development to loss of exclusivity, we simplify complexity, unlock value, and make collaboration seamless at every pivotal moment – accelerating the path from innovation to access.
How many employees does MEDiSTRAVA, an Inizio Company have?
MEDiSTRAVA, an Inizio Company has around 98 employees on LinkedIn.
Where is MEDiSTRAVA, an Inizio Company headquartered?
MEDiSTRAVA, an Inizio Company is headquartered in London, England.
Where does MEDiSTRAVA, an Inizio Company have offices?
MEDiSTRAVA, an Inizio Company lists 2 office locations, including London, England WC2A 1AN, GB; Manhattan, New York, US.
Build a lead list from companies like MEDiSTRAVA, an Inizio Company
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.